Skip to Content

Letermovir use while Breastfeeding

Drugs containing Letermovir: Prevymis

Medically reviewed by Drugs.com. Last updated on April 16, 2021.

Letermovir Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the use of letermovir during breastfeeding. Because letermovir is 99% bound to plasma proteins, the amount in milk is likely to be very low. However, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Letermovir

CAS Registry Number

917389-32-3

Drug Class

  • Breast Feeding
  • Lactation
  • Anti-Infective Agents
  • Antiviral Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.